Form 8-K - Current report:
SEC Accession No. 0001641172-25-000154
Filing Date
2025-03-21
Accepted
2025-03-21 16:31:31
Documents
44
Period of Report
2025-03-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45089
2 ex99-1.htm EX-99.1 27176
3 ex99-1_001.jpg GRAPHIC 74242
4 ex99-1_002.jpg GRAPHIC 200499
5 ex99-1_003.jpg GRAPHIC 162624
6 ex99-1_004.jpg GRAPHIC 98772
7 ex99-1_005.jpg GRAPHIC 30824
8 ex99-1_006.jpg GRAPHIC 95535
9 ex99-1_007.jpg GRAPHIC 72717
10 ex99-1_008.jpg GRAPHIC 480939
11 ex99-1_009.jpg GRAPHIC 112551
12 ex99-1_010.jpg GRAPHIC 30317
13 ex99-1_011.jpg GRAPHIC 136651
14 ex99-1_012.jpg GRAPHIC 128362
15 ex99-1_013.jpg GRAPHIC 120458
16 ex99-1_014.jpg GRAPHIC 107803
17 ex99-1_015.jpg GRAPHIC 35451
18 ex99-1_016.jpg GRAPHIC 98593
19 ex99-1_017.jpg GRAPHIC 102686
20 ex99-1_018.jpg GRAPHIC 114686
21 ex99-1_019.jpg GRAPHIC 62500
22 ex99-1_020.jpg GRAPHIC 104298
23 ex99-1_021.jpg GRAPHIC 79424
24 ex99-1_022.jpg GRAPHIC 31108
25 ex99-1_023.jpg GRAPHIC 92118
26 ex99-1_024.jpg GRAPHIC 127272
27 ex99-1_025.jpg GRAPHIC 98724
28 ex99-1_026.jpg GRAPHIC 119740
29 ex99-1_027.jpg GRAPHIC 106182
30 ex99-1_028.jpg GRAPHIC 46380
31 ex99-1_029.jpg GRAPHIC 24998
32 ex99-1_030.jpg GRAPHIC 127839
  Complete submission text file 0001641172-25-000154.txt   4693561

Data Files

Seq Description Document Type Size
33 XBRL SCHEMA FILE maia-20250321.xsd EX-101.SCH 3024
34 XBRL LABEL FILE maia-20250321_lab.xml EX-101.LAB 34240
35 XBRL PRESENTATION FILE maia-20250321_pre.xml EX-101.PRE 22365
46 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3786
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 25760991
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)